43 PRIMECAP Management Charles River Laboratories International Trades
PRIMECAP Management acquired 273 Thousand Charles River Laboratories International shares worth $37.9 Million. That's 0.03% of their equity portfolio (195th largest holding). PRIMECAP Management started to build up the position in Charles River Laboratories International in Q1 2013 and continued to invest until Q3 2013. Since then they sold 1.42 Million shares. The stake costed the investor $11.6 Million, netting the investor a gain of 227% so far.
News about Charles River Laboratories International Inc. and PRIMECAP Management
Charles River Laboratories to Present at William Blair and Jefferies Conferences
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 44th...
Titian Software: Titian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management Software
The new 3-year agreement deepens a long-standing relationship between the two companies and provides Charles River with new opportunities to support future g...
T. Rowe Price Expands Use of Cloud-Based Charles River® IMS
BOSTON–(BUSINESS WIRE)–#assetmanagement–Charles River Development, a State Street Company, announced today that T. Rowe Price will transition to Charles Rive...
Charles River Laboratories to Present at Barclays Global Healthcare Conference
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Barclays 26th Annual Global Healthcare Conference on W...